Hydrochloric Acid

Hydrochloric Acid

SCHEMBL869841

Cn1ccn(C)[c+]1Cl.[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1996434 0.69
Bromide SCHEMBL1537042 0.62
Fluoride Ion SCHEMBL1896294 0.62
SCHEMBL7558319 0.59
Hydrochloric Acid SCHEMBL11305415 0.58
Hydrochloric Acid SCHEMBL8003554 0.55
SCHEMBL18773169 0.47
SCHEMBL10017669 0.40
Hydrochloric Acid SCHEMBL72335 0.38
Hydrochloric Acid SCHEMBL42423 0.38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 605 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111718713-A Carbon dot, preparation method and application thereof, and solid luminescent forming material 中南民族大学 2020-09-29 CN claimed
EP-1924577-B1 SUBSTITUTED BENZIMIDAZOLES AND METHODS OF PREPARATION NOVARTIS AG (CH) 2011-03-30 EP claimed
US-20100256375-A1 SUBSTITUTED BENZIMIDAZOLES AND METHODS OF PREPARATION NOVARTIS VACCINES AND DIAGNOSTICS, INC. 2010-10-07 US claimed
US-7767820-B2 Substituted benzimidazoles and methods of preparation NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2010-08-03 US claimed
US-20080287682-A1 Substituted benzimidazoles and methods of preparation NOVARTIS AG 2008-11-20 US claimed
EP-1924577-A1 SUBSTITUTED BENZIMIDAZOLES AND METHODS OF PREPARATION Novartis AG (CH) 2008-05-28 EP claimed
WO-2007027950-A1 SUBSTITUTED BENZIMIDAZOLES AND METHODS OF PREPARATION NOVARTIS AG (CH) 2007-03-08 WO claimed
US-20070049622-A1 Substituted benzimidazoles and methods of preparation NOVARTIS AG 2007-03-01 US claimed
US-6384228-B2 EPIBATIDINE; ANALGESICS; ANIMAL EXTRACTS NIHON MEDI-PHYSICS CO., LTD. (JP) 2002-05-07 US claimed
US-20020010339-A1 METHOD FOR SYNTHESIS OF HALOPYRIDYL-ACYCLOPENTANE DERIVATIVE AND INTERMEDIATE THEREOF NIHON MEDI-PHYSICS CO., LTD. (JP) 2002-01-24 US claimed
US-6313321-B1 Process for preparing β-hydroxy-γ-butyrolactones and β-(meth)acryloyloxy-γ-butrolactones MITSUBISHI RAYON CO., LTD. (JP) 2001-11-06 US claimed
EP-0322765-B1 NEW THIAZOLIDINE DERIVATIVES, PROCESS FOR PREPARING SAME AND ANTI-AMNESTIC COMPOSITION CONTAINING SAME KABUSHIKI KAISHA YAKULT HONSHA (JP) 1993-08-04 EP claimed
EP-0322765-A2 New thiazolidine derivatives, process for preparing same and anti-amnestic composition containing same KABUSHIKI KAISHA YAKULT HONSHA (JP) 1989-07-05 EP claimed
JP-6234725-A None JP disclosed
JP-7138215-A None JP disclosed
JP-4308538-A None JP disclosed
JP-H04308538-A HALOGENATION SHIRATORI SEIYAKU KK 1992-10-30 JP disclosed
US-5158970-A Prolylendopeplidase inhibitors; antiamnesia KABUSHIKI KAISHA YAKULT HONSHA (JP) 1992-10-27 US disclosed
EP-0384341-A2 New proline derivatives KABUSHIKI KAISHA YAKULT HONSHA (JP) 1990-08-29 EP disclosed
JP-H02111770-A CONDENSATION COMPOUND FOR SYNTHESIS OF PEPTIDE HODOGAYA CHEM CO LTD 1990-04-24 JP disclosed